We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+27.1%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$168M
AUM Growth
+$5.88M
Cap. Flow
-$6.82M
Cap. Flow %
-4.05%
Top 10 Hldgs %
44.13%
Holding
98
New
36
Increased
11
Reduced
15
Closed
33

Top Buys

1
AMAG
AMAG Pharmaceuticals
AMAG
+$4.08M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$2.7M
3
MMSI icon
Merit Medical Systems
MMSI
+$2.6M
4
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
+$2.51M
5
HSTO
Histogen Inc. Common Stock
HSTO
+$2.3M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$10.6M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$3.44M
3
SPNC
Spectranetics Corp
SPNC
+$3.42M
4
MZOR
Mazor Robotics Ltd.
MZOR
+$3.42M
5
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$3.34M

Sector Composition

1 Healthcare 44.95%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
76
Zimmer Biomet
ZBH
$17.6B
– –
-36,050
Closed -$3.26M
NUVA
77
CALL
DELISTED
NuVasive, Inc.
NUVA
– –
-200,000
Closed -$6.47M
ACGN
78
DELISTED
Aceragen Inc
ACGN
– –
-4,048
Closed -$2.55M
ISEE
79
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-20,000
Closed -$647K
CLVS
80
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-30,000
Closed -$1.81M
GNMK
81
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-190,000
Closed -$2.52M
ELGX
82
DELISTED
Endologix Inc
ELGX
– –
-5,000
Closed -$872K
MZOR
83
DELISTED
Mazor Robotics Ltd.
MZOR
– –
-175,000
Closed -$3.42M
WINT
84
DELISTED
Windtree Therapeutics Inc
WINT
– –
-7,143
Closed -$225K
ARIA
85
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-130,000
Closed -$887K
SGNT
86
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
– –
-100,000
Closed -$2.54M
HTWR
87
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-35,600
Closed -$3.34M
NSPH
88
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-20,000
Closed -$916K
THOR
89
CALL
DELISTED
THORATEC CORPORATION
THOR
– –
-100,000
Closed -$3.66M
VOLC
90
DELISTED
VOLCANO CORPORATION COM STK
VOLC
– –
-85,000
Closed -$1.86M
AUXL
91
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-100,000
Closed -$2.07M
CBST
92
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
– –
-50,000
Closed -$3.44M
BEAT
93
DELISTED
BioTelemetry, Inc.
BEAT
– –
-125,000
Closed -$993K
CELG
94
DELISTED
Celgene Corp
CELG
– –
-20,000
Closed -$1.69M
AIRM
95
DELISTED
Air Methods Corp
AIRM
– –
-20,000
Closed -$1.17M
AGN
96
CALL
DELISTED
Allergan Inc
AGN
– –
-100,000
Closed -$11.1M
1 2 3
4

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Ghost Tree Capital held 98 positions worth $168M, up 3.6% from $163M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ghost Tree Capital withdrew a net $6.82M in Q1 2014, closing 33 positions and reducing 15 holdings. Its most notable exit was Gilead Sciences, an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 50% a quarter earlier, followed by Technology.

Against the trend, Ghost Tree Capital opened a new position in AMAG Pharmaceuticals worth $3.72M.

  • Ghost Tree Capital's largest Q1 2014 buy was AMAG Pharmaceuticals: 192,057 shares worth $3.72M.
  • Ghost Tree Capital added most to CHELSEA THERAPEUTICS INT'L LTD in Q1 2014, an estimated $2.51M increase.
  • Ghost Tree Capital's biggest Q1 2014 reduction was Spectranetics Corp, cutting an estimated $3.42M.
  • Ghost Tree Capital fully exited Gilead Sciences in Q1 2014, selling an estimated $10.6M.
  • Ghost Tree Capital's ten largest holdings make up 44% of its $168M portfolio in Q1 2014.
  • Ghost Tree Capital opened 36 new positions and closed 33 in Q1 2014.
  • Ghost Tree Capital's portfolio value rose 3.6% quarter-over-quarter to $168M.

Based on Ghost Tree Capital's 13F filing for Q1 2014, filed 15 May 2014.